Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Benign Prostatic Hyperplasia Treatment
1.2 Key Market Segments
1.2.1 Benign Prostatic Hyperplasia Treatment Segment by Type
1.2.2 Benign Prostatic Hyperplasia Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Benign Prostatic Hyperplasia Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Benign Prostatic Hyperplasia Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Benign Prostatic Hyperplasia Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Benign Prostatic Hyperplasia Treatment Market Competitive Landscape
3.1 Global Benign Prostatic Hyperplasia Treatment Sales by Manufacturers (2019-2024)
3.2 Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Benign Prostatic Hyperplasia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Benign Prostatic Hyperplasia Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Benign Prostatic Hyperplasia Treatment Sales Sites, Area Served, Product Type
3.6 Benign Prostatic Hyperplasia Treatment Market Competitive Situation and Trends
3.6.1 Benign Prostatic Hyperplasia Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Benign Prostatic Hyperplasia Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Benign Prostatic Hyperplasia Treatment Industry Chain Analysis
4.1 Benign Prostatic Hyperplasia Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Benign Prostatic Hyperplasia Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Benign Prostatic Hyperplasia Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Benign Prostatic Hyperplasia Treatment Sales Market Share by Type (2019-2024)
6.3 Global Benign Prostatic Hyperplasia Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Benign Prostatic Hyperplasia Treatment Price by Type (2019-2024)
7 Benign Prostatic Hyperplasia Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Benign Prostatic Hyperplasia Treatment Market Sales by Application (2019-2024)
7.3 Global Benign Prostatic Hyperplasia Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Benign Prostatic Hyperplasia Treatment Sales Growth Rate by Application (2019-2024)
8 Benign Prostatic Hyperplasia Treatment Market Segmentation by Region
8.1 Global Benign Prostatic Hyperplasia Treatment Sales by Region
8.1.1 Global Benign Prostatic Hyperplasia Treatment Sales by Region
8.1.2 Global Benign Prostatic Hyperplasia Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Benign Prostatic Hyperplasia Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Benign Prostatic Hyperplasia Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Benign Prostatic Hyperplasia Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Benign Prostatic Hyperplasia Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Benign Prostatic Hyperplasia Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott
9.1.1 Abbott Benign Prostatic Hyperplasia Treatment Basic Information
9.1.2 Abbott Benign Prostatic Hyperplasia Treatment Product Overview
9.1.3 Abbott Benign Prostatic Hyperplasia Treatment Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Benign Prostatic Hyperplasia Treatment SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Allergan plc
9.2.1 Allergan plc Benign Prostatic Hyperplasia Treatment Basic Information
9.2.2 Allergan plc Benign Prostatic Hyperplasia Treatment Product Overview
9.2.3 Allergan plc Benign Prostatic Hyperplasia Treatment Product Market Performance
9.2.4 Allergan plc Business Overview
9.2.5 Allergan plc Benign Prostatic Hyperplasia Treatment SWOT Analysis
9.2.6 Allergan plc Recent Developments
9.3 Astellas Pharma
9.3.1 Astellas Pharma Benign Prostatic Hyperplasia Treatment Basic Information
9.3.2 Astellas Pharma Benign Prostatic Hyperplasia Treatment Product Overview
9.3.3 Astellas Pharma Benign Prostatic Hyperplasia Treatment Product Market Performance
9.3.4 Astellas Pharma Benign Prostatic Hyperplasia Treatment SWOT Analysis
9.3.5 Astellas Pharma Business Overview
9.3.6 Astellas Pharma Recent Developments
9.4 Asahi Kasei Corporation
9.4.1 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Basic Information
9.4.2 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Product Overview
9.4.3 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Product Market Performance
9.4.4 Asahi Kasei Corporation Business Overview
9.4.5 Asahi Kasei Corporation Recent Developments
9.5 Boehringer Ingelheim GmbH
9.5.1 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Basic Information
9.5.2 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Product Overview
9.5.3 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Product Market Performance
9.5.4 Boehringer Ingelheim GmbH Business Overview
9.5.5 Boehringer Ingelheim GmbH Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Basic Information
9.6.2 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Product Overview
9.6.3 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Pfizer
9.7.1 Pfizer Benign Prostatic Hyperplasia Treatment Basic Information
9.7.2 Pfizer Benign Prostatic Hyperplasia Treatment Product Overview
9.7.3 Pfizer Benign Prostatic Hyperplasia Treatment Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Sanofi
9.8.1 Sanofi Benign Prostatic Hyperplasia Treatment Basic Information
9.8.2 Sanofi Benign Prostatic Hyperplasia Treatment Product Overview
9.8.3 Sanofi Benign Prostatic Hyperplasia Treatment Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 Teva Pharmaceutical Industries
9.9.1 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Basic Information
9.9.2 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Product Overview
9.9.3 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Product Market Performance
9.9.4 Teva Pharmaceutical Industries Business Overview
9.9.5 Teva Pharmaceutical Industries Recent Developments
9.10 Merck
9.10.1 Merck Benign Prostatic Hyperplasia Treatment Basic Information
9.10.2 Merck Benign Prostatic Hyperplasia Treatment Product Overview
9.10.3 Merck Benign Prostatic Hyperplasia Treatment Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 Boston Scientific Corporation
9.11.1 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Basic Information
9.11.2 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Product Overview
9.11.3 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Product Market Performance
9.11.4 Boston Scientific Corporation Business Overview
9.11.5 Boston Scientific Corporation Recent Developments
9.12 Teleflex Incorporated
9.12.1 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Basic Information
9.12.2 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Product Overview
9.12.3 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Product Market Performance
9.12.4 Teleflex Incorporated Business Overview
9.12.5 Teleflex Incorporated Recent Developments
9.13 Endo International
9.13.1 Endo International Benign Prostatic Hyperplasia Treatment Basic Information
9.13.2 Endo International Benign Prostatic Hyperplasia Treatment Product Overview
9.13.3 Endo International Benign Prostatic Hyperplasia Treatment Product Market Performance
9.13.4 Endo International Business Overview
9.13.5 Endo International Recent Developments
9.14 Urologix
9.14.1 Urologix Benign Prostatic Hyperplasia Treatment Basic Information
9.14.2 Urologix Benign Prostatic Hyperplasia Treatment Product Overview
9.14.3 Urologix Benign Prostatic Hyperplasia Treatment Product Market Performance
9.14.4 Urologix Business Overview
9.14.5 Urologix Recent Developments
9.15 LISA Laser
9.15.1 LISA Laser Benign Prostatic Hyperplasia Treatment Basic Information
9.15.2 LISA Laser Benign Prostatic Hyperplasia Treatment Product Overview
9.15.3 LISA Laser Benign Prostatic Hyperplasia Treatment Product Market Performance
9.15.4 LISA Laser Business Overview
9.15.5 LISA Laser Recent Developments
9.16 Olympus
9.16.1 Olympus Benign Prostatic Hyperplasia Treatment Basic Information
9.16.2 Olympus Benign Prostatic Hyperplasia Treatment Product Overview
9.16.3 Olympus Benign Prostatic Hyperplasia Treatment Product Market Performance
9.16.4 Olympus Business Overview
9.16.5 Olympus Recent Developments
10 Benign Prostatic Hyperplasia Treatment Market Forecast by Region
10.1 Global Benign Prostatic Hyperplasia Treatment Market Size Forecast
10.2 Global Benign Prostatic Hyperplasia Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Benign Prostatic Hyperplasia Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Benign Prostatic Hyperplasia Treatment Market Size Forecast by Region
10.2.4 South America Benign Prostatic Hyperplasia Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Benign Prostatic Hyperplasia Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Benign Prostatic Hyperplasia Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia Treatment by Type (2025-2030)
11.1.2 Global Benign Prostatic Hyperplasia Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Benign Prostatic Hyperplasia Treatment by Type (2025-2030)
11.2 Global Benign Prostatic Hyperplasia Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Benign Prostatic Hyperplasia Treatment Sales (K Units) Forecast by Application
11.2.2 Global Benign Prostatic Hyperplasia Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings